This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Beth Israel Deaconess Medical Center, Inc., Cornell University, Pfizer Corporation. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 539 
1 out of 2,954 
1 out of 4,488 
Years Active: 2025
Title: Hui Liu - Innovator in Targeted Therapy
Introduction
Hui Liu is a prominent inventor based in Wayland, MA (US). She has made significant contributions to the field of targeted therapy, particularly through her work on CDCP1 antibodies and antibody drug conjugates. Her innovative approach aims to enhance therapeutic options for patients.
Latest Patents
Hui Liu holds 1 patent related to her research on CUB domain-containing protein 1 (CDCP1)-targeted therapy. This patent provides materials and methods that could potentially revolutionize treatment strategies in oncology.
Career Highlights
Throughout her career, Hui Liu has worked with esteemed organizations such as Beth Israel Deaconess Medical Center and Pfizer Corporation. Her experience in these institutions has allowed her to develop and refine her expertise in the biomedical field.
Collaborations
Hui Liu has collaborated with notable professionals, including Lewis C. Cantley and Stephen P. Soltoff. These partnerships have further enriched her research and contributed to advancements in targeted therapies.
Conclusion
Hui Liu's work exemplifies the impact of innovative research in medicine. Her contributions to CDCP1-targeted therapy highlight the importance of continued exploration in the field of biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile